SMTL ID : 7d60.1

Cryo-EM Structure of human CALHM5 in the presence of rubidium red

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

homo-11-mer

Ligands

55 x PA8: 1,2-DIOCTANOYL-SN-GLYCERO-3-PHOSPHATE(Non-covalent)

PA8.1: 10 residues within 4Å: Chain A: T.16, V.17, Y.20, S.21, S.194, R.202 Chain B: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.2: 6 residues within 4Å: Chain A: G.66, L.69, N.70, N.71 Chain K: Q.14 Ligands: PA8.4 Ligand excluded by PLIP PA8.3: 8 residues within 4Å: Chain A: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.4: 6 residues within 4Å: Chain A: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.2 Ligand excluded by PLIP PA8.5: 6 residues within 4Å: Chain A: R.32, N.121, Q.176 Chain B: L.33, V.37, K.40 Ligand excluded by PLIP PA8.6: 10 residues within 4Å: Chain B: T.16, V.17, Y.20, S.21, S.194, R.202 Chain C: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.7: 6 residues within 4Å: Chain A: Q.14 Chain B: G.66, L.69, N.70, N.71 Ligands: PA8.9 Ligand excluded by PLIP PA8.8: 8 residues within 4Å: Chain B: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.9: 6 residues within 4Å: Chain B: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.7 Ligand excluded by PLIP PA8.10: 6 residues within 4Å: Chain B: R.32, N.121, Q.176 Chain C: L.33, V.37, K.40 Ligand excluded by PLIP PA8.11: 10 residues within 4Å: Chain C: T.16, V.17, Y.20, S.21, S.194, R.202 Chain D: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.12: 6 residues within 4Å: Chain B: Q.14 Chain C: G.66, L.69, N.70, N.71 Ligands: PA8.14 Ligand excluded by PLIP PA8.13: 8 residues within 4Å: Chain C: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.14: 6 residues within 4Å: Chain C: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.12 Ligand excluded by PLIP PA8.15: 6 residues within 4Å: Chain C: R.32, N.121, Q.176 Chain D: L.33, V.37, K.40 Ligand excluded by PLIP PA8.16: 10 residues within 4Å: Chain D: T.16, V.17, Y.20, S.21, S.194, R.202 Chain E: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.17: 6 residues within 4Å: Chain C: Q.14 Chain D: G.66, L.69, N.70, N.71 Ligands: PA8.19 Ligand excluded by PLIP PA8.18: 8 residues within 4Å: Chain D: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.19: 6 residues within 4Å: Chain D: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.17 Ligand excluded by PLIP PA8.20: 6 residues within 4Å: Chain D: R.32, N.121, Q.176 Chain E: L.33, V.37, K.40 Ligand excluded by PLIP PA8.21: 10 residues within 4Å: Chain E: T.16, V.17, Y.20, S.21, S.194, R.202 Chain F: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.22: 6 residues within 4Å: Chain D: Q.14 Chain E: G.66, L.69, N.70, N.71 Ligands: PA8.24 Ligand excluded by PLIP PA8.23: 8 residues within 4Å: Chain E: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.24: 6 residues within 4Å: Chain E: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.22 Ligand excluded by PLIP PA8.25: 6 residues within 4Å: Chain E: R.32, N.121, Q.176 Chain F: L.33, V.37, K.40 Ligand excluded by PLIP PA8.26: 10 residues within 4Å: Chain F: T.16, V.17, Y.20, S.21, S.194, R.202 Chain G: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.27: 6 residues within 4Å: Chain E: Q.14 Chain F: G.66, L.69, N.70, N.71 Ligands: PA8.29 Ligand excluded by PLIP PA8.28: 8 residues within 4Å: Chain F: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.29: 6 residues within 4Å: Chain F: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.27 Ligand excluded by PLIP PA8.30: 6 residues within 4Å: Chain F: R.32, N.121, Q.176 Chain G: L.33, V.37, K.40 Ligand excluded by PLIP PA8.31: 10 residues within 4Å: Chain G: T.16, V.17, Y.20, S.21, S.194, R.202 Chain H: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.32: 6 residues within 4Å: Chain F: Q.14 Chain G: G.66, L.69, N.70, N.71 Ligands: PA8.34 Ligand excluded by PLIP PA8.33: 8 residues within 4Å: Chain G: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.34: 6 residues within 4Å: Chain G: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.32 Ligand excluded by PLIP PA8.35: 6 residues within 4Å: Chain G: R.32, N.121, Q.176 Chain H: L.33, V.37, K.40 Ligand excluded by PLIP PA8.36: 10 residues within 4Å: Chain H: T.16, V.17, Y.20, S.21, S.194, R.202 Chain I: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.37: 6 residues within 4Å: Chain G: Q.14 Chain H: G.66, L.69, N.70, N.71 Ligands: PA8.39 Ligand excluded by PLIP PA8.38: 8 residues within 4Å: Chain H: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.39: 6 residues within 4Å: Chain H: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.37 Ligand excluded by PLIP PA8.40: 6 residues within 4Å: Chain H: R.32, N.121, Q.176 Chain I: L.33, V.37, K.40 Ligand excluded by PLIP PA8.41: 10 residues within 4Å: Chain I: T.16, V.17, Y.20, S.21, S.194, R.202 Chain J: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.42: 6 residues within 4Å: Chain H: Q.14 Chain I: G.66, L.69, N.70, N.71 Ligands: PA8.44 Ligand excluded by PLIP PA8.43: 8 residues within 4Å: Chain I: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.44: 6 residues within 4Å: Chain I: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.42 Ligand excluded by PLIP PA8.45: 6 residues within 4Å: Chain I: R.32, N.121, Q.176 Chain J: L.33, V.37, K.40 Ligand excluded by PLIP PA8.46: 10 residues within 4Å: Chain J: T.16, V.17, Y.20, S.21, S.194, R.202 Chain K: L.65, F.68, L.69, W.74 Ligand excluded by PLIP PA8.47: 6 residues within 4Å: Chain I: Q.14 Chain J: G.66, L.69, N.70, N.71 Ligands: PA8.49 Ligand excluded by PLIP PA8.48: 8 residues within 4Å: Chain J: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.49: 6 residues within 4Å: Chain J: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.47 Ligand excluded by PLIP PA8.50: 6 residues within 4Å: Chain J: R.32, N.121, Q.176 Chain K: L.33, V.37, K.40 Ligand excluded by PLIP PA8.51: 10 residues within 4Å: Chain A: L.65, F.68, L.69, W.74 Chain K: T.16, V.17, Y.20, S.21, S.194, R.202 Ligand excluded by PLIP PA8.52: 6 residues within 4Å: Chain J: Q.14 Chain K: G.66, L.69, N.70, N.71 Ligands: PA8.54 Ligand excluded by PLIP PA8.53: 8 residues within 4Å: Chain K: Y.98, Q.102, L.105, V.109, S.194, T.197, T.198, A.201 Ligand excluded by PLIP PA8.54: 6 residues within 4Å: Chain K: K.15, G.19, Y.20, F.22, L.26 Ligands: PA8.52 Ligand excluded by PLIP PA8.55: 6 residues within 4Å: Chain A: L.33, V.37, K.40 Chain K: R.32, N.121, Q.176 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, J. et al., Cryo-EM structures of human calcium homeostasis modulator 5. Cell Discov (2020)

Release Date

2020-12-23

Peptides

Calcium homeostasis modulator protein 5: ABCDEFGHIJK

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

E
E

F
F

G
G

H
H

I
I

J
J

K
K

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Calcium homeostasis modulator protein 5

Related Entries With Identical Sequence